Skip to main content

Month: August 2021

F-star Therapeutics to Announce Second Quarter Results and Host Conference Call on August 12, 2021

CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — F-star Therapeutics, Inc. (NASDAQ: FSTX), a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced today that it will release earnings for the quarter ending June 30, 2021 before market open on August 12, 2021. The Company will host an investor conference call and webcast that same day at 9:00 a.m. EST to discuss financial results and provide a corporate update. To access the call, participants may join via a live webcast on the Investors and News section of the F-star Therapeutics website, under Events and Presentations. To join by phone, participants may dial 1-833-471-0868 in the US/Canada or 1-914-987-7751 for international calls or 0800 0288438...

Continue reading

Decisions of the Extraordinary General Meeting of Shareholders of “Žemaitijos pienas”, AB of the 2nd of August, 2021

The Extraordinary Meeting of Shareholders of “ŽEMAITIJOS PIENAS”,AB (registered office at Sedos str. 35, Telšiai, company code 180240752, hereinafter referred to as “the Company”), held on the 2nd of August, 2021, adopted decisions on all the items on the agenda (the decisions are attached hereto), also the new wording of the Articles of Association is attached.G. Keliauskas + 370 687 18399,AttachmentsVAS sprendimas Decision (LT EN) 20210802ZP PUBLIC LIMITED LIABILITY COMPANY ENG 2021

Continue reading

Northrop Grumman Corporation Commences Exchange Offers and Consent Solicitations

FALLS CHURCH, Va., Aug. 02, 2021 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) (“Northrop Grumman”) announced today that it has commenced offers to eligible holders to exchange (each, an “Exchange Offer” and, collectively, the “Exchange Offers”) any and all outstanding notes of its direct wholly owned subsidiary, Northrop Grumman Systems Corporation (“NGSC”), as set forth in the table below (the “Existing Notes”) for (1) up to $1,171,189,000 aggregate principal amount of new notes issued by Northrop Grumman (the “New Notes”) and (2) cash. The following table sets forth the Exchange Consideration, Early Tender Premium and Total Exchange Consideration for each series of Existing Notes:Title of Series/ CUSIPNumber of ExistingNotes   Maturity Date   AggregatePrincipal AmountOutstanding   ExchangeConsideration(1)   Early...

Continue reading

Error in file containing data for prepayments (CK93) – Nykredit Realkredit A/S

To Nasdaq Copenhagen          Error in file containing data for prepayments (CK93) Nykredit has discovered that one of the two files containing prepayment data which we published earlier today contains incorrect data. The affected file is named eordinf.xml and contains prepayment data for all callable ISINs issued by the Nykredit Group except older ISINs issued by Totalkredit. Nykredit is in the process of compiling a new file which will be published as soon as it has been completed. Questions may be addressed to Nykredit Realkredit A/S, Group Treasury, Head of Investor Relations Morten Bækmand Nielsen tel +45 44 55 15 21. ***AttachmentsError in CK93 – Nykredit Realkredit A_S – 02-08-2021Korrektion – XML – Ekstraordinære indfrielser_Prepayments – Nykredit Realkredit A_S...

Continue reading

Rapid Therapeutic Announces Private Placement of $1.9 Million Convertible Notes

DALLAS, Aug. 02, 2021 (GLOBE NEWSWIRE) — Rapid Therapeutic Science Laboratories, Inc. (OTC Pink: RTSL) (“RTSL” or the “Company”), an SEC fully-reporting, growth-oriented aerosol manufacturing company focused on delivery of non-psychoactive cannabinoid compounds, announced today that it has entered into a definitive agreement with an institutional investor for the sale of a convertible promissory note with a principal amount of $1.9 million and warrants to purchase shares of the Company’s common stock, which will result in total gross proceeds of approximately $1.7 million. The closing of the offering is subject to customary closing conditions. Maxim Group LLC is acting as the sole placement agent for the offering. The convertible promissory note and warrants (and shares of common stock underlying the convertible promissory note...

Continue reading

Transaction in connection with share buy-back program

Announcement A.P. Møller – Mærsk A/S – Transactions in connection with share buy-back program On 18 November 2020, A.P. Møller – Mærsk A/S (the Company) announced a share buy-back program of DKK 10bn in compliance with the EU Commission Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 (the “Safe Harbour Regulation”).  The first phase, which started on 1 December 2020, was completed on 29 April 2021. The total market value of the shares acquired in the first phase amounted to DKK 3.3 bn. During the second phase of the program running from 12 May 2021 up to 30 September 2021, the Company will buy-back A and B shares for an amount of up to DKK 6.7bn. The following transactions have been made under the program in the period Monday 26 July...

Continue reading

Branded Legacy, Inc. Expands Spikes CBDX Sales

Spikes CBDX Opens New Accounts Longwood, FL, Aug. 02, 2021 (GLOBE NEWSWIRE) — Branded Legacy, Inc. (OTCQB: BLEG), a holding company focused on the commercial development of hemp and cannabinoid-infused beverages, along with an array of CBD topicals and tinctures, partners with new wholesale accounts in Shelby, NC and Gainesville, FL.  The Company hits the ground running after the launch of the new Delta-8 product selling through the first purchase order. The Spikes CBDX team grows sales with new wholesale account, Bradley Sports in Shelby, NC. Bradley Sports has ties with Chairman of the Board, Brandon Spikes, and wants to be a part of expanding the brand.  Additionally, the Company grows sales of the entire Spikes CBDX lineup with new partner Sacred Leaf Shops at 3743 W University Ave, Gainesville, FL 32607. Sacred Leaf is a CBD...

Continue reading

Moon Equity Holdings Corp. Details Its Acquisition of Royal Costino LLC and Outlines Next Acquisition of Mining Processing Facility in Peru

Delray Beach, FL, Aug. 02, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Moon Equity Holdings Corp. (OTC symbol MONI) provides details of its recently announced acquisition of Royal Costino LLC. Royal Costino LLC was acquired as our wholly owned subsidiary which has been operational since 2013. Anthony Cappaze has been appointed President of our new Mining Division. Anthony Cappaze is responsible for processing and exporting over 100,000 ounces of gold over the last three years that were sold at an average of $1,500 per ounce. Royal Costino LLC generated over $28 million in revenues for 10 months between 2019 and 2020 but delayed operations due to Covid. This acquisition completes the first step of the first phase of our two mining acquisitions. Royal Costino LLC is exploring numerous other mining opportunities for future acquisitions. Royal...

Continue reading

North America Handbag Market to Reach USD 17.91 Billion by 2028; Rising Need to Own Purses for Daily Usage among Women to Boost Growth, says Fortune Business Insights™

Top companies covered in North America handbag market report are Tapestry Inc. (New York, U.S.), Michael Kors USA (New York, U.S.), LVHM (Paris, France), Longchamp (Paris, France), Vera Bradley Sales LLC (Indiana, U.S.), CHANEL LIMITED (London, U.K.), Tory Burch LLC (New York, U.S.), Kering Pinault S.A. (Paris, France), PVH Corp. (New York, U.S.), Prada Holding S.P.A. (Milan, Italy) and more players profiled Pune, India, Aug. 02, 2021 (GLOBE NEWSWIRE) — North America handbag market size was USD 10.34 billion in 2020. The market is estimated to grow from USD 11.31 billion in 2021 to USD 17.91 billion in 2028 at a CAGR of 6.8% in the 2021-2028 period. This report is published by Fortune Business Insights™, in its report, titled, “North America Handbag Market, 2021-2028.” As per our analysts, the increasing fashion industry influence...

Continue reading

urban-gro, Inc. Completes Acquisition of MJ12 Design Studio and Forecasts the Addition of $7-$9M of High Margin Services Revenue

Management expects MJ12 Design Studio and its parent company to generate $7-$9 million of revenue and $1.5-$2.0 million of Adjusted EBITDA over the next 12-month period; Management expects that the synergies of adding architectural planning and design services to its existing solutions offering will add incremental engineering services and cultivation equipment revenues of more than $10 million over the next 12-month period; Acquisition drives high margin services revenue and adds approximately 70 open projects, allowing the Company to now offer on-site project management and complete design packages for retail, extraction facilities, and processing facilities. LAFAYETTE, Colo., Aug. 02, 2021 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), a fully-integrated architectural, engineering and cultivation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.